Surat Dexa Scan Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 13-12-2024
- Paid Up Capital ₹ 0.48 M
as on 13-12-2024
- Company Age 20 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 72.95%
(FY 2022)
- Profit 91.43%
(FY 2022)
- Ebitda 76.28%
(FY 2022)
- Net Worth -3.54%
(FY 2022)
- Total Assets 11.11%
(FY 2022)
About Surat Dexa Scan
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.48 M, as per Ministry of Corporate Affairs (MCA) records.
Kamalnayan Limdi, Bankimbhai Desai, Sunita Vadel, and Four other members serve as directors at the Company.
- CIN/LLPIN
U74940GJ2004PTC043471
- Company No.
043471
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jan 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Surat Dexa Scan?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamalnayan Limdi  | Director | 05-Feb-2004 | Current |
| Bankimbhai Desai | Director | 05-Mar-2004 | Current |
| Sunita Vadel | Director | 05-Feb-2004 | Current |
| Bharatkumar Naik | Director | 05-Mar-2004 | Current |
| Ajay Bhardwaj | Director | 05-Mar-2004 | Current |
| Girish Pokharna | Director | 20-Jan-2004 | Current |
Financial Performance and Corporate Structure Insights of Surat Dexa Scan.
Surat Dexa Scan Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 72.95% increase. The company also saw a substantial improvement in profitability, with a 91.43% increase in profit. The company's net worth dipped by a decrease of 3.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Surat Dexa Scan?
In 2022, Surat Dexa Scan had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vigilplus Security Solutions Private LimitedActive 14 years 2 monthsAjay Bhardwaj is a mutual person
Ngd Infraprojects Limited Liability Part NershipActive 8 years 11 monthsBankimbhai Desai is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Surat Dexa Scan?
Unlock and access historical data on people associated with Surat Dexa Scan, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Surat Dexa Scan, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Surat Dexa Scan's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
